An Unresectable Malignant Perivascular Epithelioid Cell Tumor Resistant To Multiple Combined Chemotherapies A Unique Case Report

Junjie Peng,Baohua Yu,Jian Wang,Xiaonan Hong,Ye Xu,Sanjun Cai
DOI: https://doi.org/10.1097/MPH.0b013e3181b8700b
2010-01-01
Journal of Pediatric Hematology/Oncology
Abstract:Malignant perivascular epithelioid cell tumor (PEComa) was a kind of rare disease with malignant behavior and poor prognosis. Nearly all PEComas show immunoactivity for HMB45. The treatment strategy for malignant PEComa is still of controversy, especially in advanced or unresectable disease. We reported a 14-year-old patient of unresectable malignant PEComa, who was treated with multiple combined chemotherapies. The patient died of tumor 9 months after surgery, although 3 different combined chemotherapeutic regimens and antiangiogenic drug were used. Our case suggested that empirical chemotherapeutic regimens for soft tissue sarcomas might not be suitable for PEComa.
What problem does this paper attempt to address?